On the public citation graph
Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
0 signed · 573 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.283.11.1445openalex-snapshot
Rifampin and Pyrazinamide vs Isoniazid for Prevention of Tuberculosis in HIV-Infected Persons An International Randomized Trial
inferredcites →https://doi.org/10.1001/jamapediatrics.2014.3158openalex-snapshot
Treatment for Preventing Tuberculosis in Children and Adolescents
inferredcites →https://doi.org/10.1007/s11255-004-6251-6openalex-snapshot
Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient
inferredcites →https://doi.org/10.1016/0140-6736(93)91817-6openalex-snapshot
Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection
inferredcites →https://doi.org/10.1016/j.jclinepi.2012.03.013openalex-snapshot
GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations
inferredcites →https://doi.org/10.1016/s0025-7753(00)71496-5openalex-snapshot
Evaluación de dos pautas de quimioprofilaxis tuberculosa en pacientes infectados por el virus de la inmunodeficiencia humana
inferredcites →https://doi.org/10.1016/s0025-7753(04)74140-8openalex-snapshot
Infección tuberculosa latente en población indigente. Comparación de dos pautas terapéuticas
inferredcites →https://doi.org/10.1016/s0140-6736(11)60204-3openalex-snapshot
6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial
inferredcites →https://doi.org/10.1016/s0140-6736(14)60162-8openalex-snapshot
Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial
inferredcites →https://doi.org/10.1016/s0140-6736(97)06532-xopenalex-snapshot
Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection
inferredcites →https://doi.org/10.1016/s0213-005x(03)72942-5openalex-snapshot
Ensayo clínico aleatorizado de tres pautas de quimioprofilaxis para prevenir la tuberculosis en pacientes infectados por el VIH con anergia cutánea
inferredcites →https://doi.org/10.1016/s0213-005x(03)72943-7openalex-snapshot
Tratamiento directamente observado de la infección tuberculosa latente: estudio comparativo de dos pautas con isoniacida
inferredcites →https://doi.org/10.1016/s0962-8479(96)90007-6openalex-snapshot
Short course chemoprophylaxis with rifampicin, isoniazid and pyrazinamide for tuberculosis evaluated in gold miners with chronic silicosis: A double-blind placebo controlled trial
inferredcites →https://doi.org/10.1016/s8756-3452(08)70243-3openalex-snapshot
Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection—United States, 2003
inferredcites →https://doi.org/10.1056/nejm199707313370505openalex-snapshot
A Controlled Trial of Isoniazid in Persons with Anergy and Human Immunodeficiency Virus Infection Who Are at High Risk for Tuberculosis
inferredcites →https://doi.org/10.1056/nejm199709183371201openalex-snapshot
A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency Virus
inferredcites →https://doi.org/10.1056/nejmoa1005136openalex-snapshot
New Regimens to Prevent Tuberculosis in Adults with HIV Infection
inferredcites →https://doi.org/10.1056/nejmoa1011214openalex-snapshot
Primary Isoniazid Prophylaxis against Tuberculosis in HIV-Exposed Children
inferredcites →https://doi.org/10.1056/nejmoa1104875openalex-snapshot
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
inferredcites →https://doi.org/10.1056/nejmoa1507198openalex-snapshot
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
inferredcites →https://doi.org/10.1056/nejmoa1714283openalex-snapshot
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
inferredcites →https://doi.org/10.1056/nejmoa1714284openalex-snapshot
Safety and Side Effects of Rifampin versus Isoniazid in Children
inferredcites →https://doi.org/10.1056/nejmoa1806808openalex-snapshot
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis
inferredcites →https://doi.org/10.1073/pnas.0901720106openalex-snapshot
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
inferredcites →https://doi.org/10.1086/422724openalex-snapshot
Hepatotoxicity of Rifampin and Pyrazinamide in the Treatment of Latent Tuberculosis Infection in HIV-Infected Persons: Is It Different Than in HIV-Uninfected Persons?
inferredcites →https://doi.org/10.1086/427802openalex-snapshot
Short-Course Therapy with Rifampin plus Isoniazid, Compared with Standard Therapy with Isoniazid, for Latent Tuberculosis Infection: A Meta-analysis
inferredcites →https://doi.org/10.1086/429825openalex-snapshot
High Rates of Clinical and Subclinical Tuberculosis among HIV-Infected Ambulatory Subjects in Tanzania
inferredcites →https://doi.org/10.1086/520983openalex-snapshot
The Effectiveness of a 9-Month Regimen of Isoniazid Alone versus 3- and 4-Month Regimens of Isoniazid plus Rifampin for Treatment of Latent Tuberculosis Infection in Children: Results of an 11-Year Randomized Study
inferredcites →https://doi.org/10.1093/aje/kwt246openalex-snapshot
Estimated Rate of Reactivation of Latent Tuberculosis Infection in the United States, Overall and by Population Subgroup
inferredcites →https://doi.org/10.1093/cid/civ323openalex-snapshot
Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study
inferredcites →https://doi.org/10.1093/ije/2.2.153openalex-snapshot
Isoniazid Chemoprophylaxis of Latent Primary Tuberculosis: in Five Trial Centres in France from 1959 to 1969
inferredcites →https://doi.org/10.1093/jac/dku562openalex-snapshot
Isoniazid treatment to prevent TB in kidney and pancreas transplant recipients based on an interferon-γ-releasing assay: an exploratory randomized controlled trial
inferredcites →https://doi.org/10.1093/ndt/gfp489openalex-snapshot
Use of isoniazid chemoprophylaxis in renal transplant recipients
inferredcites →https://doi.org/10.1097/00002030-199707000-00006openalex-snapshot
Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults
inferredcites →https://doi.org/10.1097/00002030-200101260-00011openalex-snapshot
Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults
inferredcites →https://doi.org/10.1097/00002030-200111090-00009openalex-snapshot
Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults
inferredcites →https://doi.org/10.1097/00006199-196401320-00046openalex-snapshot
A controlled trial of isoniazid prophylaxis in mental institutions
inferredcites →https://doi.org/10.1097/00007890-199457110-00029openalex-snapshot
A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL OF PRIMARY ISONIAZID PROPHYLAXIS IN DIALYSIS AND TRANSPLANT PATIENTS
inferredcites →https://doi.org/10.1097/00042560-200111010-00018openalex-snapshot
No Effect of Isoniazid Prophylaxis for Purified Protein Derivative–Negative HIV-Infected Adults Living in a Country With Endemic Tuberculosis: Results of a Randomized Trial
inferredcites →https://doi.org/10.1097/qad.0000000000000535openalex-snapshot
Tuberculosis incidence after 36 months’ isoniazid prophylaxis in HIV-infected adults in Botswana
inferredcites →https://doi.org/10.1097/qad.0000000000001098openalex-snapshot
Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons
inferredcites →https://doi.org/10.1111/j.1399-3062.2005.00103.xopenalex-snapshot
Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy
inferredcites →https://doi.org/10.1128/aac.01124-13openalex-snapshot
Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine
inferredcites →https://doi.org/10.1136/bmj.39000.486400.55openalex-snapshot
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial
inferredcites →https://doi.org/10.1136/bmj.39489.470347.adopenalex-snapshot
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
inferredcites →https://doi.org/10.1136/bmj.d5928openalex-snapshot
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
inferredcites →https://doi.org/10.1157/13102264openalex-snapshot
Pauta corta de isoniazida y rifampicina comparada con isoniazida para la infección latente de tuberculosis. Ensayo clínico aleatorizado
inferredcites →https://doi.org/10.1157/13102265openalex-snapshot
Ensayo clínico aleatorizado para evaluar tres pautas cortas de tratamiento de la infección latente tuberculosa en pacientes infectados por el VIH
inferredcites →https://doi.org/10.1159/000454668openalex-snapshot
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
inferredcites →https://doi.org/10.1164/ajrccm.153.1.8542139openalex-snapshot
Transmission of Tuberculosis to Close Contacts of Patients With Multidrug-Resistant Tuberculosis
inferredcites →https://doi.org/10.1164/ajrccm.161.supplement_3.ats600openalex-snapshot
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
inferredcites →https://doi.org/10.1164/ajrccm/145.1.36openalex-snapshot
A Double-blind Placebo-controlled Clinical Trial of Three Antituberculosis Chemoprophylaxis Regimens in Patients with Silicosis in Hong Kong
inferredcites →https://doi.org/10.1164/arrd.1962.85.4.490openalex-snapshot
Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts.
inferredcites →https://doi.org/10.1164/arrd.1962.85.6.821openalex-snapshot
The effect of isoniazid prophylaxis on tuberculosis morbidity among household contacts of previously known cases of tuberculosis.
inferredcites →https://doi.org/10.1164/arrd.1965.92.5.732openalex-snapshot
Isoniazid prophylaxis in contacts of persons with known tuberculosis. Second report.
inferredcites →https://doi.org/10.1164/arrd.1967.95.6.935openalex-snapshot
A controlled trial of community-wide isoniazid prophylaxis in Alaska.
inferredcites →https://doi.org/10.1164/arrd.1979.119.5.827openalex-snapshot
Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies.
inferredcites →https://doi.org/10.1164/rccm.200404-478ocopenalex-snapshot
Treatment Completion and Costs of a Randomized Trial of Rifampin for 4 Months versus Isoniazid for 9 Months
inferredcites →https://doi.org/10.1164/rccm.200512-1953ocopenalex-snapshot
Weekly Rifapentine/Isoniazid or Daily Rifampin/Pyrazinamide for Latent Tuberculosis in Household Contacts
inferredcites →https://doi.org/10.1177/1078345811435973openalex-snapshot
Isoniazid vs. Rifampin for Latent Tuberculosis Infection in Jail Inmates
inferredcites →https://doi.org/10.1185/03007995.2012.747952openalex-snapshot
Update on rifampin, rifabutin, and rifapentine drug interactions
inferredcites →https://doi.org/10.1214/aos/1030563991openalex-snapshot
MCMC convergence diagnosis via multivariate bounds on log-concave densities
inferredcites →https://doi.org/10.1371/journal.pmed.1002152openalex-snapshot
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
inferredcites →https://doi.org/10.1371/journal.pone.0047400openalex-snapshot
Efficacy of a Six-Month versus a 36-Month Regimen for Prevention of Tuberculosis in HIV-Infected Persons in India: A Randomized Clinical Trial
inferredcites →https://doi.org/10.1371/journal.pone.0140881openalex-snapshot
Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012
inferredcites →https://doi.org/10.1378/chest.09-0394openalex-snapshot
Latent TB Infection Treatment Acceptance and Completion in the United States and Canada
inferredcites →https://doi.org/10.1378/chest.124.6.2112openalex-snapshot
Initial Experience on Rifampin and Pyrazinamide vs Isoniazid in the Treatment of Latent Tuberculosis Infection Among Patients With Silicosis in Hong Kong
inferredcites →https://doi.org/10.1378/chest.73.1.44openalex-snapshot
Prophylaxis with Isoniazid in Inactive Tuberculosis
inferredcites →https://doi.org/10.1378/chest.99.2.465openalex-snapshot
Toxic Hepatitis with Isoniazid and Rifampin
inferredcites →https://doi.org/10.15585/mmwr.mm6725a5openalex-snapshot
Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection
inferredcites →https://doi.org/10.18637/jss.v036.i03openalex-snapshot
Conducting Meta-Analyses in R with the metafor Package
inferredcites →https://doi.org/10.5588/ijtld.11.0504openalex-snapshot
Latent tuberculosis infection treatment for prison inmates: a randomised controlled trial
inferredcites →https://doi.org/10.5588/ijtld.12.0510openalex-snapshot
Rifampicin plus isoniazid for the prevention of tuberculosis in an immigrant population
inferredcites →https://doi.org/10.5588/ijtld.13.0354openalex-snapshot
Isoniazid preventive therapy in HIV-infected children on antiretroviral therapy: a pilot study
inferredcites →https://doi.org/10.7326/0003-4819-149-10-200811180-00003openalex-snapshot
Adverse Events with 4 Months of Rifampin Therapy or 9 Months of Isoniazid Therapy for Latent Tuberculosis Infection
inferredcites →https://doi.org/10.7326/0003-4819-81-2-200openalex-snapshot
The Effect of Isoniazid on Transaminase Levels
inferredcites →https://doi.org/10.7326/m14-1019openalex-snapshot
Treatment of Latent Tuberculosis Infection
inferredcites →https://doi.org/10.7326/m17-0609openalex-snapshot
Treatment of Latent Tuberculosis Infection
inferredcites →https://doi.org/10.7326/m17-1150openalex-snapshot
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4012588openalex-extracted
Positive Rates of Interferon-γ Release Assay and Tuberculin Skin Test in Detection of Latent Tuberculosis Infection: A Systematic Review and Meta-Analysis of 200,000 Head-to-Head Comparative Tests
inferred← citeshttps://doi.org/10.1001/jama.2022.24362openalex-snapshot
Management of Latent Tuberculosis Infection
inferred← citeshttps://doi.org/10.1001/jama.2023.4899openalex-snapshot
Screening for Latent Tuberculosis Infection in Adults
inferred← citeshttps://doi.org/10.1001/jama.2023.4967openalex-snapshot
Screening for Latent Tuberculosis Infection Among Non–US-Born Adults in the US
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2023.12114openalex-snapshot
Screening for Latent Tuberculosis Infection
inferred← citeshttps://doi.org/10.1002/9781683670438.mcm0014openalex-snapshot
Prevention of Laboratory‐Acquired Infections
inferred← citeshttps://doi.org/10.1002/9781683670438.mcm0031openalex-snapshot
Mycobacterium tuberculosis Complex
inferred← citeshttps://doi.org/10.1002/9781683670438.mcm0031.pub2openalex-snapshot
Mycobacterium tuberculosis Complex
inferred← citeshttps://doi.org/10.1002/9781683674023.ch28openalex-snapshot
Interferon Gamma Release Assays for Tuberculosis Diagnosis
inferred← citeshttps://doi.org/10.1002/ccr3.8838openalex-snapshot
Disseminated tuberculosis after Polatuzumab‐Vedotin based chemoimmunotherapy in a patient with Burkitt's lymphoma
inferred← citeshttps://doi.org/10.1002/cpdd.1517openalex-snapshot
Effect of High‐Fat Diets on the Pharmacokinetics of Bedaquiline Fumarate Tablet: A Trial in Healthy Chinese Participants
inferred← citeshttps://doi.org/10.1002/fsn3.4227openalex-snapshot
Aqueous extract‐mediated green synthesis of CuO nanoparticles: Potential anti‐tuberculosis agents
inferred← citeshttps://doi.org/10.1002/hep.32689openalex-snapshot
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
inferred← citeshttps://doi.org/10.1002/iju5.70063openalex-snapshot
A Case of Advanced Urothelial Carcinoma Requiring Treatment Following a Positive Interferon‐Gamma Release Assay Prior to Avelumab Administration
inferred← citeshttps://doi.org/10.1002/mco2.419openalex-snapshot
Mycobacterium tuberculosis : immune response, biomarkers, and therapeutic intervention
inferred← citeshttps://doi.org/10.1002/phar.2672openalex-snapshot
Systematic review of drug–drug interactions between rifamycins and anticoagulant and antiplatelet agents and considerations for management
inferred← citeshttps://doi.org/10.1007/978-1-0716-1807-3_11openalex-snapshot
Prevention and Control of Tuberculosis in Correctional Facilities
inferred← citeshttps://doi.org/10.1007/978-3-030-55490-3_2openalex-snapshot
Bactericidal, Fungicidal, and Immunomodulating Activities of Nanosurfaces
inferred← citeshttps://doi.org/10.1007/978-3-030-67459-5_22openalex-snapshot
Clinical Approach to Treatment of Mycobacterial Infections
inferred← citeshttps://doi.org/10.1007/978-3-030-92938-1_2openalex-snapshot
Laboratory Monitoring: HIV, TB and Hepatitis
inferred← citeshttps://doi.org/10.1007/978-3-031-04998-9_7openalex-snapshot
Polypharmacology in Clinical Applications: Respiratory Polypharmacology
inferred← citeshttps://doi.org/10.1007/978-3-031-15955-8_27openalex-snapshot
Challenges for Contact Tracing and Tuberculosis Preventive Therapy Scale-up
inferred← citeshttps://doi.org/10.1007/978-3-031-84089-0_14openalex-snapshot
Tuberculosis: Hemoptysis with Unexplained Fevers and Weight Loss
inferred← citeshttps://doi.org/10.1007/978-981-16-9053-2_25openalex-snapshot
Immunodeficiency and Abdominal Tuberculosis
inferred← citeshttps://doi.org/10.1007/978-981-19-3995-2_10openalex-snapshot
Advances in Treatment of Latent TB Infection: What Is the Latest Approach to Treat Latent TB Infection to Prevent Pulmonary TB?
inferred← citeshttps://doi.org/10.1007/978-981-92-0256-0_4openalex-snapshot
Treatment, Challenges, and Opportunity of Latent Tuberculosis Infection
inferred← citeshttps://doi.org/10.1007/s00108-025-02039-4openalex-snapshot
Positiver Interferon-γ-release-Assay und Immunsuppression – leitliniengerechtes Management der Tuberkuloseinfektion
inferred← citeshttps://doi.org/10.1007/s00393-022-01274-6openalex-snapshot
Consensus Statement der Österreichischen Gesellschaften für Rheumatologie und Rehabilitation, Pneumologie, Infektiologie, Dermatologie und Gastroenterologie zum Umgang mit latenter Tuberkulose bei Therapien mit biologischen oder „targeted synthetic“ DMARDs („disease modifying antirheumatic drugs“)
inferred← citeshttps://doi.org/10.1007/s00467-026-07180-2openalex-snapshot
Infection prophylaxis following anti-CD20 monoclonal antibodies in childhood kidney diseases
inferred← citeshttps://doi.org/10.1007/s00508-022-02062-7openalex-snapshot
National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs)
inferred← citeshttps://doi.org/10.1007/s10067-021-05969-0openalex-snapshot
Safety of latent tuberculosis infection treatment in older patients with immune-mediated inflammatory diseases
inferred← citeshttps://doi.org/10.1007/s10067-024-06867-xopenalex-snapshot
The Saudi consensus recommendations for the management of psoriatic arthritis (2023)
inferred← citeshttps://doi.org/10.1007/s10067-026-07932-3openalex-snapshot
Minimizing missed latent tuberculosis infection under adalimumab: real-world data from a BCG-vaccinated cohort
inferred← citeshttps://doi.org/10.1007/s10096-025-05301-7openalex-snapshot
Managing tuberculosis infection among migrants from high-incidence tuberculosis countries: challenges, strategies and recommendations
inferred← citeshttps://doi.org/10.1007/s10096-025-05382-4openalex-snapshot
Establishing a clinical tool to predict acute kidney injury in pulmonary tuberculosis: insights from a large-scale retrospective study
inferred← citeshttps://doi.org/10.1007/s10096-026-05435-2openalex-snapshot
The diagnostic yield of brushing versus non-brushing bronchoalveolar lavage fluid for Xpert MTB/RIF in patients with suspected tuberculosis: a prospective self-controlled study
inferred← citeshttps://doi.org/10.1007/s10096-026-05471-yopenalex-snapshot
Screening and treatment practices for tuberculosis infection in Nordic, Baltic and Central European countries and Ukraine in 2023
inferred← citeshttps://doi.org/10.1007/s10238-025-01959-7openalex-snapshot
Non-TNF-targeted drugs in rheumatic diseasescombined with latent tuberculosis infection
inferred← citeshttps://doi.org/10.1007/s10620-021-07056-5openalex-snapshot
Prevalence of Latent Tuberculosis Infection Among Persons with Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1007/s10903-021-01231-6openalex-snapshot
Epidemiology and Prevention of Tuberculosis and Chronic Hepatitis B Virus Infection in the United States
inferred← citeshttps://doi.org/10.1007/s10903-022-01438-1openalex-snapshot
Can Primary Care Drive Tuberculosis Elimination? Increasing Latent Tuberculosis Infection Testing and Treatment Initiation at a Community Health Center with a Large Non-U.S.-born Population
inferred← citeshttps://doi.org/10.1007/s10903-026-01891-2openalex-snapshot
Willingness to Receive Latent Tuberculosis Infection Treatment Among Migrants in Tijuana, Baja California, Mexico
inferred← citeshttps://doi.org/10.1007/s11606-023-08551-3openalex-snapshot
Randomized Controlled Trial of Clinical Guidelines Versus Interactive Decision-Support for Improving Medical Trainees’ Confidence with Latent Tuberculosis Care
inferred← citeshttps://doi.org/10.1007/s11904-020-00529-8openalex-snapshot
Are We There Yet? Short-Course Regimens in TB and HIV: From Prevention to Treatment of Latent to XDR TB
inferred← citeshttps://doi.org/10.1007/s11908-020-00726-xopenalex-snapshot
Latent Tuberculosis and HIV Infection
inferred← citeshttps://doi.org/10.1007/s12094-024-03433-4openalex-snapshot
Screening and treatment of latent tuberculosis in patients with solid tumors and systemic cancer therapy
inferred← citeshttps://doi.org/10.1007/s12094-025-03958-2openalex-snapshot
Previous history of solid tumor in patients presenting tuberculosis: a multicenter retrospective study in a low-tuberculosis-incidence area
inferred← citeshttps://doi.org/10.1007/s12098-023-04969-zopenalex-snapshot
Tuberculosis Preventive Treatment
inferred← citeshttps://doi.org/10.1007/s12325-025-03453-8openalex-snapshot
Immunotherapy for Melanoma in Patients with Altered Immune Systems: Unique Challenges and Clinical Considerations
inferred← citeshttps://doi.org/10.1007/s15010-024-02239-4openalex-snapshot
Incipient tuberculosis: a comprehensive overview
inferred← citeshttps://doi.org/10.1007/s40257-024-00845-4openalex-snapshot
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
inferred← citeshttps://doi.org/10.1007/s40262-021-01098-8openalex-snapshot
Drug–Drug Interaction Potential with Once-Weekly Isoniazid/Rifapentine (3HP) for the Treatment of Latent Tuberculosis Infection
inferred← citeshttps://doi.org/10.1007/s40264-021-01109-4openalex-snapshot
Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature
inferred← citeshttps://doi.org/10.1007/s40265-022-01817-wopenalex-snapshot
The Struggle to End a Millennia-Long Pandemic: Novel Candidate and Repurposed Drugs for the Treatment of Tuberculosis
inferred← citeshttps://doi.org/10.1007/s40265-024-02131-3openalex-snapshot
Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review
inferred← citeshttps://doi.org/10.1007/s40266-021-00880-4openalex-snapshot
Pulmonary Tuberculosis in Older Adults: Increased Mortality Related to Tuberculosis Within Two Months of Treatment Initiation
inferred← citeshttps://doi.org/10.1007/s44411-025-00051-6openalex-snapshot
Latent and Manifest Tuberculosis in Patients with Rheumatoid Arthritis Treated with Anticytokine Therapy
inferred← citeshttps://doi.org/10.1016/b978-0-12-818619-0.00010-1openalex-snapshot
Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/b978-0-323-75608-2.00007-0openalex-snapshot
Antimicrobial Chemoprophylaxis
inferred← citeshttps://doi.org/10.1016/b978-0-323-75608-2.00095-1openalex-snapshot
Infections in Solid Organ Transplant Recipients
inferred← citeshttps://doi.org/10.1016/b978-0-323-75608-2.00107-5openalex-snapshot
Infections Related to Biologic Response Modifying Drug Therapy
inferred← citeshttps://doi.org/10.1016/b978-0-323-75608-2.00134-8openalex-snapshot
Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/b978-0-323-75608-2.00292-5openalex-snapshot
Antibacterial Agents
inferred← citeshttps://doi.org/10.1016/b978-0-323-79058-1.00061-xopenalex-snapshot
Tuberculosis Vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-323-82763-8.00252-1openalex-snapshot
Antibacterial Therapeutic Agents
inferred← citeshttps://doi.org/10.1016/b978-0-323-85730-7.00020-5openalex-snapshot
An update on tuberculosis
inferred← citeshttps://doi.org/10.1016/b978-0-443-23571-9.00017-7openalex-snapshot
Kidney transplantation: Assessment of the Kidney Donor Candidate
inferred← citeshttps://doi.org/10.1016/j.ajem.2021.09.076openalex-snapshot
Emergency department screening for latent tuberculosis infection
inferred← citeshttps://doi.org/10.1016/j.ajo.2025.11.020openalex-snapshot
Clinical Significance of T-SPOT.TB Test in Patients With Uveitis in South Korea
inferred← citeshttps://doi.org/10.1016/j.amepre.2021.10.013openalex-snapshot
Video-Observed Therapy Versus Directly Observed Therapy in Patients With Tuberculosis
inferred← citeshttps://doi.org/10.1016/j.amjmed.2021.01.039openalex-snapshot
Update in Outpatient General Internal Medicine: Practice-Changing Evidence Published in 2020
inferred← citeshttps://doi.org/10.1016/j.amjms.2026.07.013openalex-snapshot
Diffuse alveolar hemorrhage in ANCA-associated vasculitis: Current evidence and multimodal treatment approaches
inferred← citeshttps://doi.org/10.1016/j.arbres.2026.07.006openalex-snapshot
Incidence and Risk Factors for Tuberculosis Among TBI-Positive Contacts Identified Through Contact Tracing in Catalonia
inferred← citeshttps://doi.org/10.1016/j.autrev.2025.103758openalex-snapshot
Assessment and management for latent tuberculosis before advanced therapies for immune-mediated inflammatory diseases: A comprehensive review
inferred← citeshttps://doi.org/10.1016/j.bpobgyn.2020.10.006openalex-snapshot
People living with human immunodeficiency virus and gestational trophoblastic neoplasm
inferred← citeshttps://doi.org/10.1016/j.cden.2023.02.012openalex-snapshot
An Initial Visit in a Patient with a History of Tuberculosis
inferred← citeshttps://doi.org/10.1016/j.cellin.2024.100163openalex-snapshot
Optimizing antigen selection for the development of tuberculosis vaccines
inferred← citeshttps://doi.org/10.1016/j.chpulm.2024.100103openalex-snapshot
Managing Silicosis in the United States
inferred← citeshttps://doi.org/10.1016/j.clp.2024.08.012openalex-snapshot
Prevention, Diagnosis, and Treatment of Tuberculosis in Children with Human Immunodeficiency Virus
inferred← citeshttps://doi.org/10.1016/j.cmi.2023.02.016openalex-snapshot
Treatment of latent tuberculosis infection in incarcerated people: a systematic review
inferred← citeshttps://doi.org/10.1016/j.cmi.2024.04.014openalex-snapshot
Quantitative interferon-gamma releasing assay in predicting tuberculosis in South Korean military: a retrospective cohort study
inferred← citeshttps://doi.org/10.1016/j.cnur.2024.10.004openalex-snapshot
Overview of the Epidemiology, Diagnosis, and Clinical Care Considerations for People Living with and at Risk for Tuberculosis in the United States
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2022.115885openalex-snapshot
VIDAS3® TB-IGRA assay: evaluation of performance characteristics in a predominantly low risk, low incidence population
inferred← citeshttps://doi.org/10.1016/j.eclinm.2021.100821openalex-snapshot
Ringing the alarm bell: Time to scale up drug-resistant tuberculosis preventive treatment
inferred← citeshttps://doi.org/10.1016/j.eclinm.2023.102209openalex-snapshot
Comparative effectiveness of interventions for preventing tuberculosis: systematic review and network meta-analysis of interventional studies
inferred← citeshttps://doi.org/10.1016/j.ekir.2024.04.043openalex-snapshot
Infectious Disease Prophylaxis During and After Immunosuppressive Therapy
inferred← citeshttps://doi.org/10.1016/j.focus.2023.100148openalex-snapshot
Using Electronic Health Record Data to Measure the Latent Tuberculosis Infection Care Cascade in Safety-Net Primary Care Clinics
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e22786openalex-snapshot
Analysis of prevalence of adverse events connected with anti-tuberculosis drugs during pregnancy: A meta-analysis
inferred← citeshttps://doi.org/10.1016/j.ijid.2020.03.001openalex-snapshot
Commemorating World TB Day 2020: “IT’S TIME” — It’s time to End the Global TB Epidemic
inferred← citeshttps://doi.org/10.1016/j.ijid.2021.07.024openalex-snapshot
Assessment of Interferon Gamma-Induced Protein 10 mRNA Release Assay for Detection of Latent Tuberculosis Infection in Egyptian Pediatric Household Contacts
inferred← citeshttps://doi.org/10.1016/j.ijid.2021.08.014openalex-snapshot
Interferon gamma release assays for detection of latent Mycobacterium tuberculosis in older Hispanic people
inferred← citeshttps://doi.org/10.1016/j.ijid.2021.09.010openalex-snapshot
Stages of pregnancy and HIV affect diagnosis of tuberculosis infection and Mycobacterium tuberculosis (MTB)-induced immune response: Findings from PRACHITi, a cohort study in Pune, India
inferred← citeshttps://doi.org/10.1016/j.ijid.2022.07.040openalex-snapshot
Pharmacokinetics of isoniazid and rifapentine in young pediatric patients with latent tuberculosis infection
inferred← citeshttps://doi.org/10.1016/j.ijid.2025.107914openalex-snapshot
Adverse events of tuberculosis preventive therapy among individuals with latent tuberculosis infection: A nationwide cohort study in South Korea
inferred← citeshttps://doi.org/10.1016/j.ijid.2025.107988openalex-snapshot
Low utilization of targeted tuberculosis (TB) infection testing in the United States: a 15-year serial cross-sectional study
inferred← citeshttps://doi.org/10.1016/j.ijid.2026.108564openalex-snapshot
Regional divergence in pediatric tuberculosis and implications for achieving End TB targets, 2013–2023
inferred← citeshttps://doi.org/10.1016/j.ijid.2026.108989openalex-snapshot
Response to active tuberculosis within a maternal newborn unit—military treatment facility, Alaska, April-August 2025
inferred← citeshttps://doi.org/10.1016/j.ijtb.2025.02.001openalex-snapshot
Epidemiological, and management challenges in tuberculosis with chronic kidney disease
inferred← citeshttps://doi.org/10.1016/j.ijtb.2025.02.014openalex-snapshot
Comparison of 6 months isoniazid versus 3 months isoniazid - rifampicin therapy for prevention of tuberculosis in children suffering from tuberculosis infection - A randomized controlled trial
inferred← citeshttps://doi.org/10.1016/j.jceh.2025.103120openalex-snapshot
Tuberculosis in Transplant Setting - Implications in Diagnosis, Treatment and Prevention
inferred← citeshttps://doi.org/10.1016/j.jctube.2023.100367openalex-snapshot
The latent tuberculosis infection cascade of care during the COVID-19 pandemic response in a Mid-Sized US city
inferred← citeshttps://doi.org/10.1016/j.jctube.2023.100376openalex-snapshot
Fluoroquinolone-resistant latent tuberculosis infection: A literature review and case series of 5 patients treated with linezolid monotherapy
inferred← citeshttps://doi.org/10.1016/j.jctube.2023.100382openalex-snapshot
Trends in tuberculosis clinicians’ adoption of short-course regimens for latent tuberculosis infection
inferred← citeshttps://doi.org/10.1016/j.jctube.2024.100439openalex-snapshot
Characteristics and outcomes of the duration of treatment with adjunctive corticosteroids in intraocular tuberculosis
inferred← citeshttps://doi.org/10.1016/j.jctube.2025.100536openalex-snapshot
Operational considerations of select new treatment recommendations for drug-susceptible and drug-resistant tuberculosis
inferred← citeshttps://doi.org/10.1016/j.jctube.2025.100565openalex-snapshot
Tuberculosis reactivation in hematopoietic stem cell transplant recipients: a preemptive strategy in an endemic country
inferred← citeshttps://doi.org/10.1016/j.jctube.2025.100572openalex-snapshot
Latent TB treatment outcomes in patients with chronic liver disease: A retrospective cohort study
inferred← citeshttps://doi.org/10.1016/j.jctube.2026.100590openalex-snapshot
Prevalence and risk factors associated with rifampicin-induced cholestasis jaundice among tuberculosis patients in high-incidence setting: A retrospective cohort study
inferred← citeshttps://doi.org/10.1016/j.jctube.2026.100601openalex-snapshot
Analysis of knowledge, acceptance and willingness to manage tuberculosis preventive treatment among Chinese village doctors
inferred← citeshttps://doi.org/10.1016/j.jgar.2022.04.025openalex-snapshot
Advantages of short-course rifamycin-based regimens for latent tuberculosis infection: an updated network meta-analysis
inferred← citeshttps://doi.org/10.1016/j.jgar.2024.05.018openalex-snapshot
Prevalence and patterns of drug-resistant Mycobacterium tuberculosis in newly diagnosed patients in China: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.jhin.2023.11.009openalex-snapshot
Effect of a latent tuberculosis infection programme for healthcare workers in a country with an intermediate tuberculosis burden
inferred← citeshttps://doi.org/10.1016/j.jhin.2024.02.012openalex-snapshot
Management of newborns and healthcare workers exposed to isoniazid-resistant congenital tuberculosis in the neonatal intensive care unit
inferred← citeshttps://doi.org/10.1016/j.jiph.2025.102740openalex-snapshot
Early differential diagnosis models of Talaromycosis and Tuberculosis in HIV-negative hosts using clinical data and machine learning
inferred← citeshttps://doi.org/10.1016/j.jiph.2025.102917openalex-snapshot
Adherence to tuberculosis infection treatment and its impact on prevention of tuberculosis reactivation: A retrospective cohort study from Taiwan
inferred← citeshttps://doi.org/10.1016/j.jmii.2024.11.002openalex-snapshot
Drug monitoring was conducted for rifapentine among people with HIV receiving dolutegravir containing antiretroviral therapy and latent tuberculosis treatment
inferred← citeshttps://doi.org/10.1016/j.jpeds.2022.09.038openalex-snapshot
Multicenter Analysis of Attrition from the Pediatric Tuberculosis Infection Care Cascade in Boston
inferred← citeshttps://doi.org/10.1016/j.jpeds.2023.113419openalex-snapshot
Variation in Treatment of Pediatric Tuberculosis Infection in Different Provider Settings
inferred← citeshttps://doi.org/10.1016/j.jpet.2026.104950openalex-snapshot
Destabilization of TIP60-PXR complex by rifampicin impairs wound-induced cell migration
inferred← citeshttps://doi.org/10.1016/j.jpha.2023.11.005openalex-snapshot
Modern approaches for detection of volatile organic compounds in metabolic studies focusing on pathogenic bacteria: Current state of the art
inferred← citeshttps://doi.org/10.1016/j.lana.2023.100444openalex-snapshot
The impact of the COVID-19 pandemic in tuberculosis preventive treatment in Brazil: a retrospective cohort study using secondary data
inferred← citeshttps://doi.org/10.1016/j.lanwpc.2023.100770openalex-snapshot
Tuberculosis in older adults: challenges and best practices in the Western Pacific Region
inferred← citeshttps://doi.org/10.1016/j.lanwpc.2024.101047openalex-snapshot
Population-wide active case finding as a strategy to end TB
inferred← citeshttps://doi.org/10.1016/j.mcna.2022.08.001openalex-snapshot
Testing and Treating Mycobacterium tuberculosis Infection
inferred← citeshttps://doi.org/10.1016/j.med.2022.03.024openalex-snapshot
Indicaciones de la quimioprofilaxis en la infección por Mycobacterium tuberculosis en situaciones especiales, edad, comorbilidades y tratamientos coincidentes
inferred← citeshttps://doi.org/10.1016/j.med.2025.05.016openalex-snapshot
Protocolo de profilaxis y manejo de las infecciones con los tratamientos biológicos inmunomoduladores y los inhibidores de JAK
inferred← citeshttps://doi.org/10.1016/j.nurpra.2020.06.027openalex-snapshot
Tuberculosis Infection in Children
inferred← citeshttps://doi.org/10.1016/j.nurpra.2025.105557openalex-snapshot
Reframing Latent Tuberculosis Infection Screening and Treatment as a Primary Care Responsibility
inferred← citeshttps://doi.org/10.1016/j.pmedr.2023.102321openalex-snapshot
Latent tuberculosis infection in the outpatient general medicine clinic: Efficacy of a nurse-run electronic directly observed treatment program
inferred← citeshttps://doi.org/10.1016/j.ptdy.2020.04.020openalex-snapshot
Treating latent tuberculosis
inferred← citeshttps://doi.org/10.1016/j.rcreu.2024.11.001openalex-snapshot
Riesgo de tuberculosis en pacientes con inmunosupresión: en búsqueda de una vieja conocida
inferred← citeshttps://doi.org/10.1016/j.rcreue.2024.12.003openalex-snapshot
Tuberculosis risk in immunosuppressed patients: Revisiting an old acquaintance
inferred← citeshttps://doi.org/10.1016/j.reuma.2021.04.006openalex-snapshot
Recomendaciones SER sobre prevención de infección en enfermedades reumáticas autoinmunes sistémicas
inferred← citeshttps://doi.org/10.1016/j.reuma.2022.10.004openalex-snapshot
En respuesta a la Carta al Editor de los Dres. Suárez-Diaz y Caminal-Montero en referencia al artículo especial «Recomendaciones SER sobre prevención de infección en enfermedades reumáticas autoinmunes sistémicas»
inferred← citeshttps://doi.org/10.1016/j.reumae.2021.04.003openalex-snapshot
Recommendations for prevention of infection in systemic autoimmune rheumatic diseases
inferred← citeshttps://doi.org/10.1016/j.reumae.2022.10.001openalex-snapshot
Reply to the Letter to the Editor from Drs Suárez-Diaz and Caminal-Montero in reference to the special article “Recommendations for prevention of infection in systemic autoimmune rheumatic diseases”
inferred← citeshttps://doi.org/10.1016/j.tim.2022.03.010openalex-snapshot
Bag it, tag it: ubiquitin ligases and host resistance to Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/j.tmaid.2021.102185openalex-snapshot
Tuberculosis burden in immigrants and natives, adults and children, in Tuscany between 2000–2018
inferred← citeshttps://doi.org/10.1016/j.tube.2020.102041openalex-snapshot
Missed opportunities in tb clinical practice: How to bend the curve? A medical, social, economic and ethical point of view
inferred← citeshttps://doi.org/10.1016/j.vaccine.2026.128690openalex-snapshot
Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01E-4 tuberculosis vaccine
inferred← citeshttps://doi.org/10.1016/j.xfre.2022.07.008openalex-snapshot
REMOVED: Adverse pregnancy outcomes after in vitro fertilization due to undiagnosed urogenital tuberculosis and proposed screening algorithm for patients from tuberculosis-endemic countries
inferred← citeshttps://doi.org/10.1016/j.ymthe.2026.07.029openalex-snapshot
Multivalent DNA vaccines induce potent cellular responses and prolong BCG-mediated control of Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/s1166-8598(23)92252-0openalex-snapshot
10.1016/s1166-8598(23)92252-0
inferred← citeshttps://doi.org/10.1016/s1473-3099(21)00052-9openalex-snapshot
Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/s1473-3099(22)00227-4openalex-snapshot
Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia
inferred← citeshttps://doi.org/10.1016/s2211-9698(24)74422-7openalex-snapshot
Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/s2214-109x(21)00047-4openalex-snapshot
Leprosy post-exposure prophylaxis risks not adequately assessed – Author's reply
inferred← citeshttps://doi.org/10.1016/s2214-109x(24)00221-3openalex-snapshot
Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study
inferred← citeshttps://doi.org/10.1016/s2352-4642(21)00052-3openalex-snapshot
Safety and feasibility of 1 month of daily rifapentine plus isoniazid to prevent tuberculosis in children and adolescents: a prospective cohort study
inferred← citeshttps://doi.org/10.1016/s2468-1253(22)00048-6openalex-snapshot
Challenges in the management of inflammatory bowel disease in sub-Saharan Africa
inferred← citeshttps://doi.org/10.1016/s2468-2667(20)30261-9openalex-snapshot
Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial
inferred← citeshttps://doi.org/10.1016/s2468-2667(25)00306-8openalex-snapshot
The potential effect of a geographically focused intervention against tuberculosis in the USA: a simulation modelling study
inferred← citeshttps://doi.org/10.1017/ash.2025.184openalex-snapshot
Public health response to a tuberculosis exposure in a daycare: lessons on transmission risk and intervention
inferred← citeshttps://doi.org/10.1017/s0950268823002030openalex-snapshot
Cost-effectiveness of interferon-γ release assay for screening of latent tuberculosis infection in individuals with schizophrenia
inferred← citeshttps://doi.org/10.1021/acsinfecdis.4c01053openalex-snapshot
Mycobacterial Small Heat Shock Proteins: Dissecting Their Roles in Pathogenesis and Development of Therapeutics
inferred← citeshttps://doi.org/10.1038/s41467-023-44136-8openalex-snapshot
Distinct gene expression signatures comparing latent tuberculosis infection with different routes of Bacillus Calmette-Guérin vaccination
inferred← citeshttps://doi.org/10.1038/s41573-024-00897-5openalex-snapshot
Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease
inferred← citeshttps://doi.org/10.1038/s41579-022-00731-yopenalex-snapshot
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
inferred← citeshttps://doi.org/10.1038/s41591-020-1076-0openalex-snapshot
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings
inferred← citeshttps://doi.org/10.1038/s41598-022-22721-zopenalex-snapshot
Cost effectiveness analysis of single and sequential testing strategies for tuberculosis infection in adults living with HIV in the United States
inferred← citeshttps://doi.org/10.1038/s41598-023-44854-5openalex-snapshot
Gut microbiota composition and diversity before, during, and two months after rifamycin-based tuberculosis preventive therapy
inferred← citeshttps://doi.org/10.1038/s41598-024-66486-zopenalex-snapshot
Suppression of host gene expression is associated with latent TB infection: a possible diagnostic biomarker
inferred← citeshttps://doi.org/10.1038/s41598-025-31419-xopenalex-snapshot
Acceptance of preventive therapy for latent tuberculosis infection in Chinese children and adolescents: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1038/s41598-025-91753-yopenalex-snapshot
Analysis of nationwide adverse event reports on Isoniazid and Rifampin in tuberculosis prevention and treatment in South Korea
inferred← citeshttps://doi.org/10.1038/s44259-026-00238-zopenalex-snapshot
Antimicrobial peptides for tuberculosis in a post-antibiotic era: from in vitro promise to therapeutic potential
inferred← citeshttps://doi.org/10.1056/evidccon2200125openalex-snapshot
How Do I Navigate Latent Tuberculosis Diagnosis?
inferred← citeshttps://doi.org/10.1056/nejm-jw.na50934openalex-snapshot
Latent Tuberculosis Treatment Guidelines: 2020 Update
inferred← citeshttps://doi.org/10.1080/14740338.2024.2399074openalex-snapshot
Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1080/17474086.2021.1875818openalex-snapshot
Association of tuberculosis in patients with chronic myeloid leukemia: a treatment proposal based on literature review
inferred← citeshttps://doi.org/10.1080/17476348.2024.2418932openalex-snapshot
Pulmonary tuberculosis in non-HIV adults: an evergreen old-fashioned disease in high-income countries. A narrative review
inferred← citeshttps://doi.org/10.1080/17512433.2024.2317954openalex-snapshot
Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics
inferred← citeshttps://doi.org/10.1080/21655979.2021.2003930openalex-snapshot
Study on the associations between liver damage and antituberculosis drug rifampicin and relative metabolic enzyme gene polymorphisms
inferred← citeshttps://doi.org/10.1080/22221751.2024.2302099openalex-snapshot
Incidence, risk factors for active tuberculosis infection and changes of IGRA in patients with Takayasu arteritis: a prospective cohort study
inferred← citeshttps://doi.org/10.1080/23744235.2023.2228406openalex-snapshot
The cascade of care for pregnant women with latent tuberculosis infection in a high-income country
inferred← citeshttps://doi.org/10.1093/aje/kwab150openalex-snapshot
Modeling the Cost-Effectiveness of Latent Tuberculosis Screening and Treatment Strategies in Recent Migrants to a Low-Incidence Setting
inferred← citeshttps://doi.org/10.1093/brain/awab476openalex-snapshot
Susac syndrome: challenges in the diagnosis and treatment
inferred← citeshttps://doi.org/10.1093/cid/ciaa1169openalex-snapshot
Safety and Efficacy of Rifampin or Isoniazid Among People With Mycobacterium tuberculosis Infection and Living With Human Immunodeficiency Virus or Other Health Conditions: Post Hoc Analysis of 2 Randomized Trials
inferred← citeshttps://doi.org/10.1093/cid/ciaa1364openalex-snapshot
Higher Completion Rates With Self-administered Once-weekly Isoniazid-rifapentine Versus Daily Rifampin in Adults With Latent Tuberculosis
inferred← citeshttps://doi.org/10.1093/cid/ciac248openalex-snapshot
Evaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States
inferred← citeshttps://doi.org/10.1093/cid/ciad083openalex-snapshot
Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection
inferred← citeshttps://doi.org/10.1093/cid/ciad246openalex-snapshot
A Systematic Review and Meta-Analysis of Tuberculous Preventative Therapy Adverse Events
inferred← citeshttps://doi.org/10.1093/cid/ciad251openalex-snapshot
Latent Tuberculosis Infection Treatment: Still a Long Road Ahead
inferred← citeshttps://doi.org/10.1093/cid/ciad659openalex-snapshot
US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy
inferred← citeshttps://doi.org/10.1093/cid/ciad730openalex-snapshot
Treatment Responses to Integrase Strand-transfer Inhibitor-containing Antiretroviral Regimens in Combination With Short-course Rifapentine-based Regimens for Latent Tuberculosis Infection Among People With HIV
inferred← citeshttps://doi.org/10.1093/cid/ciaf088openalex-snapshot
Tuberculosis-Preventive Treatment for Household Contacts at Health Facility and Community Settings in Pakistan
inferred← citeshttps://doi.org/10.1093/cid/ciaf404openalex-snapshot
Safety, Feasibility, and Rifapentine Plasma Concentration in Chinese Children With 1 Month of Daily Rifapentine Plus Isoniazid for Tuberculosis Infection
inferred← citeshttps://doi.org/10.1093/cid/ciaf479openalex-snapshot
Infection Control in Carceral Facilities
inferred← citeshttps://doi.org/10.1093/cid/ciaf723openalex-snapshot
Short-Course Tuberculosis Preventive Therapy in a High Migration Setting: Early Experience With 1HP in Cook County, Illinois
inferred← citeshttps://doi.org/10.1093/ecco-jcc/jjaf032openalex-snapshot
Uncovering the therapeutic potential of anti-tuberculoid agent Isoniazid in a model of microbial-driven Crohn’s disease
inferred← citeshttps://doi.org/10.1093/jac/dkaf029openalex-snapshot
Pharmacokinetics and safety of rifapentine in children: dosing for latent tuberculosis infection
inferred← citeshttps://doi.org/10.1093/jpids/piac070openalex-snapshot
Testing and Scaling Interventions to Improve the Tuberculosis Infection Care Cascade
showing the first 200 of 494 · page through all 494
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.